About Indo Bioactive Labs
Indo Bioactive Labs is a company based in Pune (India) founded in 2001. Indo Bioactive Labs has raised $115.1 thousand across 1 funding round from investors including Sunfruits. Indo Bioactive Labs offers products and services including Generic Peptide APIs, Other APIs, and Formulations. Indo Bioactive Labs operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Aperiam Bio, among others.
- Headquarter Pune, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Indo-Bio Active Labs Private Limited
- Date of Incorporation 15 Feb, 1999
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$590.16 K (USD)-4.89as on Mar 31, 2023
-
Net Profit
$65.5 K (USD)-23.93as on Mar 31, 2023
-
EBITDA
$101.18 K (USD)-8.25as on Mar 31, 2023
-
Total Equity Funding
$115.1 K (USD)
in 1 rounds
-
Latest Funding Round
$115.1 K (USD), Seed
Mar 31, 2007
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indo Bioactive Labs
Indo Bioactive Labs offers a comprehensive portfolio of products and services, including Generic Peptide APIs, Other APIs, and Formulations.
Develops generic peptide active ingredients for pharmaceuticals.
Manufactures various active pharmaceutical ingredients.
Produces formulated pharmaceutical products for medical use.
Funding Insights of Indo Bioactive Labs
Indo Bioactive Labs has successfully raised a total of $115.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $115.1 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Indo Bioactive Labs
Indo Bioactive Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sunfruits.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Indo Bioactive Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indo Bioactive Labs
Investment portfolio details for Indo Bioactive Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indo Bioactive Labs
Detailed financials for Indo Bioactive Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indo Bioactive Labs Comparisons
Peer comparison for Indo Bioactive Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indo Bioactive Labs
Indo Bioactive Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Aperiam Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| Locked | Locked | Locked |
Industrial and therapeutic proteins are manufactured by Aperiam Bio.
|
|
| Locked | Locked | Locked |
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs.
|
Detailed competitors of Indo Bioactive Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indo Bioactive Labs
Complete news archive for Indo Bioactive Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indo Bioactive Labs
Indo Bioactive Labs was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Indo Bioactive Labs is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Indo Bioactive Labs is a funded company, having raised a total of $115.1K across 1 funding round to date.
Annual revenue of Indo Bioactive Labs is $590.16K as on Mar 31, 2023.
Indo Bioactive Labs was established in 2001 and is based in Pune, India. Operations are focused on the biotechnology and pharmaceutical sectors, where contract development and manufacturing organization (CDMO) services are delivered. Specialization occurs in the creation of heparin-based and peptide therapeutics, supporting research and production needs for pharmaceutical clients. The company maintains facilities in India to handle these processes.
Indo Bioactive Labs's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
Indo Bioactive Labs offers Generic Peptide APIs, Other APIs, and Formulations.
Indo Bioactive Labs has 1 investor. Key investors include Sunfruits.
The valuation of Indo Bioactive Labs is $116.5K as of Mar 2007.